Status:
COMPLETED
Phase IV Observational Study in Chronic Lymphocytic Leukemia
Lead Sponsor:
GlaxoSmithKline
Conditions:
Leukaemia, Lymphocytic, Chronic
Eligibility:
All Genders
Brief Summary
B-cell chronic lymphocytic leukemia (CLL) is a subtype of mature peripheral B-cell neoplasms, characterized by the accumulation of circulating malignant lymphocytes that typically express cell surface...
Eligibility Criteria
Inclusion
- All CLL patients who have previously received Arzerra, whether alive or deceased
- Patients who have either completed the full course of Arzerra therapy or discontinued treatment early
Exclusion
- CLL patients newly initiating Arzerra
- Patients having been treated with Arzerra in phase II or phase III clinical trials
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01453062
Start Date
September 1 2011
End Date
November 1 2012
Last Update
July 8 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.